Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1664 | 327 | 0.0641 | 0.0613 | 0.1965 | 0.2108 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1138 | 197 | 0.0477 | 0.0492 | 0.1731 | 0.1635 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2198 | 268 | 0.0925 | 0.0889 | 0.1219 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2119 | 435 | 0.0807 | 0.0825 | 0.2053 | 0.1694 |
A-375 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1639 | 365 | 0.0611 | 0.0613 | 0.2227 | 0.2108 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2902 | 98 | 0.1420 | 0.1658 | 0.0338 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1196 | 197 | 0.0506 | 0.0492 | 0.1647 | 0.1635 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2168 | 298 | 0.0896 | 0.0889 | 0.1375 | 0.1262 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 3068 | 107 | 0.1499 | 0.1658 | 0.0349 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 1023 | 106 | 0.0464 | 0.0490 | 0.1036 | 0.0884 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1188 | 84 | 0.0559 | 0.0490 | 0.0707 | 0.0884 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2204 | 325 | 0.0900 | 0.0825 | 0.1475 | 0.1694 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1899 | 295 | 0.0769 | 0.0825 | 0.1553 | 0.1694 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1396 | 73 | 0.0670 | 0.0636 | 0.0523 | 0.0545 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1388 | 90 | 0.0657 | 0.0636 | 0.0648 | 0.0545 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1204 | 56 | 0.0581 | 0.0636 | 0.0465 | 0.0545 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 967 | 88 | 0.0445 | 0.0490 | 0.0910 | 0.0884 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 4220 | 165 | 0.2053 | 0.1658 | 0.0391 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1153 | 176 | 0.0495 | 0.0492 | 0.1526 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2327 | 89 | 0.1133 | 0.0917 | 0.0382 | 0.0407 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1659 | 68 | 0.0806 | 0.0917 | 0.0410 | 0.0407 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1677 | 72 | 0.0813 | 0.0917 | 0.0429 | 0.0407 |
A-375 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1436 | 338 | 0.0526 | 0.0534 | 0.2354 | 0.2441 |
A-375 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1557 | 332 | 0.0587 | 0.0613 | 0.2132 | 0.2108 |